Here are relevant reports on : continuous-glucose-monitoring-devices-market
-
Cardiovascular Devices Market by Product (Cardiac Imaging, Rhythm Management, Cardiac Assist Devices, Interventional Cardiology, Electrophysiology, Monitoring ), Indication (CAD, MI, CHF), End User (Hospitals & Clinics) - Global Forecast to 2029
The global cardiovascular devices market, valued at US$72.83 billion in 2023, stood at US$77.71 billion in 2024 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2029, culminating in a forecasted valuation of US$110.39 billion by the end of the period. The growth of the cardiovascular devices market is primarily due to the increasing prevalence of CVD, the aging population, and the growing prevalence of risk factors like diabetes, hypertension, obesity, and sedentary lifestyle.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) & Region - Global Forecast to 2029
The global cardiac monitoring & cardiac rhythm management devices market, valued at US$20.7 billion in 2023, stood at US$21.3 billion in 2024 and is projected to advance at a resilient CAGR of 4.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.4 billion by the end of the period. Market growth in the Asia Pacific can be attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking, and rising morbidity and mortality from CVD.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Neonatal Care Equipment Market by Product (Neonatal Incubators, Convertible Warmers & Incubators, Respiratory Care Devices (Neonatal Ventilators), Monitoring Devices (Pulse Oximeters)), End User (General and Pediatric Hospitals) - Global Forecast to 2030
The global neonatal care equipment market, valued at US$2.0 billion in 2024, stood at US$2.2 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The neonatal care equipment market is driven by rising preterm birth rates, advancements in neonatal technology, and increasing government initiatives to reduce infant mortality.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Medical Devices and Supplies Market by Product (Anesthesia, Patient Monitoring, Infusion Pumps, Consumables), Application (Diagnosis, Monitoring, Therapy, Surgical), Animal Type (Companion Animals, Large Animals) - Global Forecast to 2030
The global veterinary medical devices and supplies market, valued at US$2.50 billion in 2024, stood at US$2.66 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$3.60 billion by the end of the period. The market growth is driven by the rising pet ownership and increasing expenditure on animal healthcare, coupled with the growing prevalence of chronic and infectious diseases in companion and livestock animals.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Glucose, Dextrose, and Maltodextrin Market by Product (Glucose, Dextrose, and Maltodextrin), Application (Food & Beverages (Confectionery, Bakery, Dairy), Pharmaceuticals, Personal Care Products, Paper & Pulp), and Region - Global Forecast to 2024
The glucose, dextrose, and maltodextrin market is projected to reach USD 51.87 billion by 2024, at a CAGR of 7.0% from 2018, in terms of value. The market is driven by the increase in demand from the beverage industry, intense research & development activities, and increase in demand for convenience foods. The demand for glucose, dextrose, and maltodextrin in the food & beverages segment is expected to witness significant growth in the near future, as major food & beverage companies are expected to increase the application of glucose, dextrose, and maltodextrin due to their multiple benefits, including their role as sweeteners, binders, emulsifiers, and thickening agents. This report studies the marketing and development strategies, along with the product portfolios of leading companies such as ADM (US), Ingredion (US), AGRANA (Austria), Tate & Lyle (UK), Cargill (US), ROQUETTE (France), Grain Processing Corporation (US), Avebe Group (Netherlands), Tereos (France), Global Sweeteners Holdings (Hong Kong), Gulshan Polyols (India), and Fooding Group Limited (China).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Continuous Manufacturing Market By Product (Integrated system, Semi-continuous (Granulator, Coater, Blender), Control), Application (API, End Product (Solid Dosage)), End User (R&D Department (CRO), Pharmaceutical Companies, CMO)- Global Forecast to 2022
The global continuous manufacturing market is projected to grow at a CAGR of 13.3%. Major players in this market include GEA Group AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bosch Packaging Technology (Germany), Coperion GmbH (Germany), and Glatt GmbH (Germany). Other players include KORSCH AG (Germany), Munson Machinery Company, Inc. (U.S.), L.B. Bohle Maschinen + Verfahren Gmbh (Germany), Gebrüder Lödige Maschinenbau GmbH (Germany), Baker Perkins Ltd. (U.K.), Scott Equipment Company (U.S.), and Sturtevant, Inc. (U.S.).
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Anesthesia Monitoring Devices Market by Product (Basic Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstations), End User (Hospital, Ambulatory Surgery Centers), and Geography - Global Forecast to 2020
The requirement of anesthesia monitoring devices basically depends on the types of cases performed in the operating room. The parameters to be considered for anesthesia monitoring devices include continuous assessment by measurement of patient’s oxygenation, ventilation, circulation, and temperature. The global anesthesia monitoring devices market was valued at USD 820.9 Million in 2014 and is expected to reach USD 1,616.0 Million by 2020, at a CAGR of 12.0% from 2015 to 2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
Low Voltage Protection and Control Market by Product Type (Protection Equipment, Switching Equipment, and Monitoring Devices), End-use (Residential, Commercial, and Industrial (Oil & Gas, EV Charging), and Region - Global Forecast to 2025
The global low voltage protection and control market is projected to reach a size of USD 19.8 billion by 2025, at a CAGR of 5.97%, from an estimated USD 13.2 billion in 2018. This growth can be attributed to factors such as growth in the demand for renewable energy sources, growing per capita consumption of energy, and safe and secure electrical systems.ABB (Switzerland), Eaton (Ireland), Fuji Electric co. ltd (Japan), Hitachi (Japan), Rockwell Automation (US), Schneider Electric (France), Siemens (Germany), Yaskawa (Japan), CHINT Group (China), WEG SA (Brazil), Legrand (France), Toshiba (Japan), and Emerson Electric Co. (US).
- Published: February 2019
- Price: $ 4950
- TOC Available:
-
Fetal Monitoring Market by Product (Ultrasound, Fetal Monitors, Telemetry Devices, Fetal Electrodes), Portability (Portable, Non-portable), Method (Invasive, Non-invasive), Application (Antepartum, Intrapartum), End User & Region - Global Forecast to 2027
The global fetal monitoring market in terms of revenue was estimated to be worth $3.7 billion in 2022 and is poised to reach $5.2 billion by 2027, growing at a CAGR of 7.3% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Clinical Trial Services Market by Type (Laboratory, Monitoring, Recruitment, PV, Data Management), Phase (I, II, III), Therapy (Oncology, Neurology, Dermatology, CVD), Modality (Biologics, Devices), Delivery Model (FSP, Hybrid) - Global Forecast to 2030
The global Clinical Trial Services market, valued at US$60.76 billion in 2024, stood at US$66.59 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$101.86 billion by the end of the period. Factors such as the growing focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs) and the increasing number of clinical trials for precision/personalized medicines are supporting the growth of this market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
